VNDA
- Vanda Pharmaceuticals Inc.
()
Overview
Company Summary
Vanda Pharmaceuticals Inc. is a biopharmaceutical company that specializes in the development and commercialization of innovative therapies for central nervous system disorders. The company's primary focus is on advancing products for the treatment of mood disorders, neurological disorders, and sleep disorders.
Vanda Pharmaceuticals is best known for its FDA-approved products, including Fanapt� (iloperidone) and Hetlioz� (tasimelteon). Fanapt is an antipsychotic medication used for the treatment of schizophrenia in adults, while Hetlioz is indicated for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) in both blind individuals and those with sight.
In addition to its existing portfolio, Vanda Pharmaceuticals is devoted to researching, developing, and discovering potential therapies for various psychiatric and neurologic conditions. They conduct clinical trials and collaborate with healthcare professionals, researchers, and patient advocacy groups to better understand and address the unmet medical needs in these areas.
Through their commitment to scientific innovation and clinical development, Vanda Pharmaceuticals aims to improve the lives of patients suffering from central nervous system disorders by providing effective and safe treatment options.